AssayIndex
Reports by quarter

Reports submitted in 2025-Q3 · page 7

Kestrel Bioanalytical began contributing; gradient-length normalisation introduced. Median purity for the quarter is 98.79 % area, n=819. Read the 2025-Q3 state-of-the-index report →

819 records21 pagesmedian on this page 98.56 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-021052SemaglutideWXTWXT-2508-G4316VendorInvestigate2025-Q397.422.53101.8Buyer-sourced2MARGINAL
AX-2025-020827GHRP-6SGNSGN-2504-X1136Janoshik2025-Q398.623.52106.7Supplier-supplied1FAIL
AX-2025-020733TirzepatideSGNSGN-2506-J8941Janoshik2025-Q396.512.52—Supplier-supplied3FAIL
AX-2025-020517GHK-CuKPKP-2502-C5740Janoshik2025-Q398.464.22105.0Supplier-supplied0PASS
AX-2025-020495CJC-1295 with DACKPKP-2506-L5639Janoshik2025-Q399.805.00—Supplier-supplied0PASS
AX-2025-020361LiraglutideMKMMKM-2508-P3929Janoshik2025-Q398.556.99103.4Supplier-supplied1MARGINAL
AX-2025-020355LiraglutideMKMMKM-2508-P3929Medutest2025-Q398.856.89—Supplier-supplied0PASS
AX-2025-020110TirzepatideGGPepsGGPE-2502-J8885Janoshik2025-Q398.195.7993.6Supplier-supplied2MARGINAL
AX-2025-019240BPC-157TFCTFC-2507-J6580Kestrel2025-Q399.834.31105.2Supplier-supplied1MARGINAL
AX-2025-020889Thymosin α1CPCCPC-2504-M1855PeptideMeter2025-Q397.904.86—Supplier-supplied0PASS
AX-2025-020357LiraglutideMKMMKM-2508-P3929Medutest2025-Q398.586.30—Supplier-supplied0FAIL
AX-2025-020111TirzepatideGGPepsGGPE-2502-J8885Janoshik2025-Q398.295.48106.3Supplier-supplied2MARGINAL
AX-2025-019808SemaglutideHJHJ-2507-P3933Nordanalyt2025-Q399.634.3397.2Supplier-supplied1MARGINAL
AX-2025-019235NAD+TFCTFC-2505-C6056VendorInvestigate2025-Q399.0112.14—Buyer-sourced1FAIL
AX-2025-019213BPC-157TFCTFC-2508-W5717PeptideMeter2025-Q399.693.54—Supplier-supplied1MARGINAL
AX-2025-018686DihexaQYBQYB-2503-Y6694Janoshik2025-Q399.937.89105.8Supplier-supplied0PASS
AX-2025-020689SemaglutideGL BiochemGLBI-2505-V8283PeptideMeter2025-Q397.704.9788.9Supplier-supplied2MARGINAL
AX-2025-020192MK-677 (Ibutamoren mesylate)GGPepsGGPE-2507-S1153Medutest2025-Q399.774.7797.8Buyer-sourced2FAIL
AX-2025-020122RetatrutideGGPepsGGPE-2508-E8992Janoshik2025-Q397.622.84103.9Supplier-supplied1MARGINAL
AX-2025-020034RetatrutideERPERP-2506-C7220Janoshik2025-Q398.265.59100.9Supplier-supplied3MARGINAL
AX-2025-019690BPC-157HJHJ-2503-M3088Janoshik2025-Q399.935.2297.1Supplier-supplied0PASS
AX-2025-019200TB-500TFCTFC-2503-R5803Janoshik2025-Q398.543.55—Buyer-sourced1MARGINAL
AX-2025-018865DesmopressinQSCQSC-2505-N8999Janoshik2025-Q399.484.06100.2Supplier-supplied0PASS
AX-2025-018856DesmopressinQSCQSC-2505-N8999PeptideMeter2025-Q399.934.3689.0Supplier-supplied1MARGINAL
AX-2025-018695RetatrutideQSCQSC-2502-D6580VendorInvestigate2025-Q397.517.2491.2Buyer-sourced1MARGINAL
AX-2025-021298AOD-9604BCHBCH-2504-B8049Janoshik2025-Q398.752.7197.3Supplier-supplied0PASS
AX-2025-021248L-Glutathione (reduced)BCHBCH-2508-X6429Janoshik2025-Q397.486.36—Supplier-supplied0FAIL
AX-2025-020795PT-141 (Bremelanotide)SGNSGN-2505-A9617Janoshik2025-Q398.073.8293.4Laboratory-retained1FAIL
AX-2025-020568VilonSSASSA-2508-B6325Nordanalyt2025-Q399.465.77105.5Supplier-supplied0FAIL
AX-2025-020566VilonSSASSA-2508-B6325VendorInvestigate2025-Q399.045.78—Buyer-sourced0FAIL
AX-2025-0202955-Amino-1MQMKMMKM-2503-H2930PeptideMeter2025-Q399.565.20102.6Supplier-supplied2FAIL
AX-2025-020260CJC-1295 (no DAC)MKMMKM-2504-K2481Janoshik2025-Q397.934.7097.3Supplier-supplied1FAIL
AX-2025-0199465-Amino-1MQSWBSWB-2507-E6159Kestrel2025-Q399.936.60—Supplier-supplied1FAIL
AX-2025-019752SemaglutideHJHJ-2507-Y3362VendorInvestigate2025-Q397.263.9390.8Buyer-sourced1MARGINAL
AX-2025-019558SemaglutideHomopeptideHOMO-2506-M1846Medutest2025-Q398.145.74—Buyer-sourced1MARGINAL
AX-2025-019195IGF-1 LR3TFCTFC-2508-H6012Janoshik2025-Q397.755.55—Supplier-supplied0PASS
AX-2025-018611PemvidutideQYBQYB-2502-V5083Janoshik2025-Q399.293.7394.5Supplier-supplied3MARGINAL
AX-2025-021296AOD-9604BCHBCH-2504-B8049Janoshik2025-Q398.962.5397.1Supplier-supplied0PASS
AX-2025-020900SemaglutideCPCCPC-2504-G2724Janoshik2025-Q398.545.04104.8Supplier-supplied2MARGINAL
AX-2025-020794PT-141 (Bremelanotide)SGNSGN-2505-A9617Janoshik2025-Q398.353.8297.3Supplier-supplied1FAIL